An increased CD4+/CD8+ T-cell ratio has been reported in patients with severe COVID-19 [60,61], suggesting that SARS-CoV-2 infection might preferentially impair CD8+ T cells, especially from the effector memory population [57]. The gene discussed is CD8A; the disease is COVID-19.